A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis

NCT00993317 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

127

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

DRUG: Placebo of CDP870
DRUG: CDP870 200mg
DRUG: Methotrexate

Sponsor

Korea Otsuka Pharmaceutical Co., Ltd.